{"id":7819,"date":"2024-11-27T00:18:21","date_gmt":"2024-11-27T00:18:21","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=7819"},"modified":"2024-11-27T00:18:21","modified_gmt":"2024-11-27T00:18:21","slug":"anvisa-paineis-cadifa","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/","title":{"rendered":"Anvisa publica pain\u00e9is sobre Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo"},"content":{"rendered":"<\/p>\n<p style=\"text-align: center;\" data-olk-copy-source=\"MessageBody\">A Anvisa (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria) publicou dois pain\u00e9is de consulta sobre a Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo (Cadifa). Esta ferramenta permite aos usu\u00e1rios verificar e acompanhar documentos emitidos, al\u00e9m de consultar a fila de an\u00e1lise desses registos.<\/p>\n<p style=\"text-align: center;\">O primeiro painel foi desenvolvido para a consulta da emiss\u00e3o da Cadifa, permitindo a verifica\u00e7\u00e3o da vers\u00e3o v\u00e1lida da carta, ou se foi suspensa ou cancelada. Informa\u00e7\u00f5es como o detentor da Cadifa, o insumo farmac\u00eautico ativo (IFA), o n\u00famero da carta, a data da \u00faltima revis\u00e3o e a situa\u00e7\u00e3o de validade da revis\u00e3o s\u00e3o exibidas. As informa\u00e7\u00f5es est\u00e3o em conformidade com as pr\u00e1ticas de autoridades internacionais que utilizam modelos regulat\u00f3rios semelhantes para o controle sanit\u00e1rio de IFA.<\/p>\n<p style=\"text-align: center;\">O segundo painel, referente \u00e0s notifica\u00e7\u00f5es de Cadifa vinculadas a p\u00f3s-registro, oferece a possibilidade de consultar a ordem de distribui\u00e7\u00e3o para an\u00e1lise dessas cartas, especialmente no contexto de peti\u00e7\u00f5es relacionadas a p\u00f3s-registro. A pesquisa pode ser realizada de diversas formas, incluindo pelo n\u00famero do expediente, categoria regulat\u00f3ria, situa\u00e7\u00e3o do p\u00f3s-registro e o n\u00famero do expediente da notifica\u00e7\u00e3o. Esses pain\u00e9is refletem o compromisso da Anvisa com a transpar\u00eancia no processo de an\u00e1lise de registros de medicamentos, conforme a Lei de Acesso \u00e0 Informa\u00e7\u00e3o (Lei 12.527\/2011).<\/p>\n<p style=\"text-align: center;\">A Cadifa \u00e9 um instrumento administrativo que certifica a adequa\u00e7\u00e3o do Dossi\u00ea de Insumo Farmac\u00eautico Ativo (Difa) \u00e0 Resolu\u00e7\u00e3o da Diretoria Colegiada (RDC) 359\/2020, e faz parte da revis\u00e3o do marco regulat\u00f3rio para IFA utilizado em medicamentos novos, inovadores, gen\u00e9ricos e similares.<\/p>\n<p style=\"text-align: center;\"><em>Na ELS Group consideramos que a\u00a0disponibiliza\u00e7\u00e3o dos pain\u00e9is sobre a Cadifa pela Anvisa \u00e9 um marco importante para o setor farmac\u00eautico, pois aprimora a transpar\u00eancia e moderniza o acompanhamento dos processos regulat\u00f3rios. Essas ferramentas permitem verificar de forma \u00e1gil o status da Cadifa, como validade, revis\u00e3o e hist\u00f3rico, al\u00e9m de monitorar a ordem de an\u00e1lise de peti\u00e7\u00f5es de p\u00f3s-registro, o que facilita o planejamento estrat\u00e9gico e reduz incertezas para as empresas.<\/em><\/p>\n<p style=\"text-align: center;\"><em>Para empresas que atuam com insumos farmac\u00eauticos ativos ou medicamentos, compreender essas mudan\u00e7as \u00e9 essencial para garantir conformidade regulat\u00f3ria e otimizar processos de registro e p\u00f3s-registro. Com o suporte certo, \u00e9 poss\u00edvel navegar por essas novas ferramentas de maneira eficiente, acelerar a regulariza\u00e7\u00e3o de produtos e minimizar riscos regulat\u00f3rios. Se precisar de mais informa\u00e7\u00f5es sobre quest\u00f5es regulat\u00f3rias, a ELS pode certamente ajudar.<\/em><\/p>\n<p style=\"text-align: center;\"><span data-olk-copy-source=\"MessageBody\">Se precisar de mais informa\u00e7\u00f5es sobre quest\u00f5es regulat\u00f3rias, a ELS pode certamente ajudar.<\/span><\/p>\n<p style=\"text-align: center;\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Por favor entre em contato com o seu <a href=\"https:\/\/els-solutions.com\/onde-estamos\/\" target=\"_blank\" rel=\"noopener\">consultor local da ELS<\/a> <\/span><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">ou atrav\u00e9s do email: <strong>info@elssolutions.pt<\/strong><\/span><\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>Esta ferramenta permite aos usu\u00e1rios verificar e acompanhar documentos emitidos, al\u00e9m de consultar a fila de an\u00e1lise desses registos.<\/p>\n","protected":false},"author":9,"featured_media":7821,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[67,68,53,65,60,69],"tags":[70,64],"class_list":["post-7819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-els","category-els-group","category-geral","category-medicamentos","category-noticias","category-questoes-regulatorias","tag-medicamentos","tag-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anvisa publica pain\u00e9is sobre Cadifa<\/title>\n<meta name=\"description\" content=\"A Anvisa publicou dois pain\u00e9is de consulta sobre a Cadifa. Esta ferramenta permite aos usu\u00e1rios verificar e acompanhar documentos emitidos, al\u00e9m de consultar a fila de an\u00e1lise desses registos.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa\" \/>\n<meta property=\"og:description\" content=\"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa para garantir o abastecimento de produtos cr\u00edticos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-27T00:18:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Anvisa publica pain\u00e9is sobre Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo\",\"datePublished\":\"2024-11-27T00:18:21+00:00\",\"dateModified\":\"2024-11-27T00:18:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\"},\"wordCount\":1433,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png\",\"keywords\":[\"medicamentos\",\"Not\u00edcias\"],\"articleSection\":[\"ELS\",\"ELS Group\",\"Geral\",\"Medicamentos\",\"Not\u00edcias\",\"Quest\u00f5es regulat\u00f3rias\"],\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\",\"name\":\"Anvisa publica pain\u00e9is sobre Cadifa\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png\",\"datePublished\":\"2024-11-27T00:18:21+00:00\",\"dateModified\":\"2024-11-27T00:18:21+00:00\",\"description\":\"A Anvisa publicou dois pain\u00e9is de consulta sobre a Cadifa. Esta ferramenta permite aos usu\u00e1rios verificar e acompanhar documentos emitidos, al\u00e9m de consultar a fila de an\u00e1lise desses registos.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png\",\"width\":1200,\"height\":600,\"caption\":\"A Anvisa (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria) publicou dois pain\u00e9is de consulta sobre a Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo (Cadifa)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa publica pain\u00e9is sobre Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa publica pain\u00e9is sobre Cadifa","description":"A Anvisa publicou dois pain\u00e9is de consulta sobre a Cadifa. Esta ferramenta permite aos usu\u00e1rios verificar e acompanhar documentos emitidos, al\u00e9m de consultar a fila de an\u00e1lise desses registos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/","og_locale":"pt_PT","og_type":"article","og_title":"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa","og_description":"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa para garantir o abastecimento de produtos cr\u00edticos.","og_url":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-11-27T00:18:21+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Marketing ELS","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Anvisa publica pain\u00e9is sobre Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo","datePublished":"2024-11-27T00:18:21+00:00","dateModified":"2024-11-27T00:18:21+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/"},"wordCount":1433,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png","keywords":["medicamentos","Not\u00edcias"],"articleSection":["ELS","ELS Group","Geral","Medicamentos","Not\u00edcias","Quest\u00f5es regulat\u00f3rias"],"inLanguage":"pt-PT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/","url":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/","name":"Anvisa publica pain\u00e9is sobre Cadifa","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png","datePublished":"2024-11-27T00:18:21+00:00","dateModified":"2024-11-27T00:18:21+00:00","description":"A Anvisa publicou dois pain\u00e9is de consulta sobre a Cadifa. Esta ferramenta permite aos usu\u00e1rios verificar e acompanhar documentos emitidos, al\u00e9m de consultar a fila de an\u00e1lise desses registos.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/11\/Anvisa-Cadifa.png","width":1200,"height":600,"caption":"A Anvisa (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria) publicou dois pain\u00e9is de consulta sobre a Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo (Cadifa)"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/pt-pt\/anvisa-paineis-cadifa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"Anvisa publica pain\u00e9is sobre Carta de Adequa\u00e7\u00e3o de Dossi\u00ea de Insumo Farmac\u00eautico Ativo"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/pt-pt\/#website","url":"https:\/\/els-solutions.com\/pt-pt\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/pt-pt\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=7819"}],"version-history":[{"count":8,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7819\/revisions"}],"predecessor-version":[{"id":7838,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7819\/revisions\/7838"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media\/7821"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=7819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/categories?post=7819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=7819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}